Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France.
第一作者:
Jérôme,Avouac
第一单位:
Rheumatology A Department, Paris Descartes University, Sorbonne Paris Cité, Cochin Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France; Paris Descartes University, Sorbonne Paris Cité, INSERM U1016, Cochin Institute, CNRS UMR8104, Paris, France. Electronic address: jerome.avouac@aphp.fr.
作者:
医学主题词
成年人(Adult);消炎药(Anti-Inflammatory Agents);关节炎, 类风湿(Arthritis, Rheumatoid);药物替代(Drug Substitution);女(雌)性(Female);法国(France);医院, 大学(Hospitals, University);人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);椎关节炎(Spondylarthritis);治疗结果(Treatment Outcome)
DOI
10.1016/j.semarthrit.2017.10.002
PMID
29102156
发布时间
2022-04-08
- 浏览9
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



